ECM
FLGT icon

Element Capital Management’s Fulgent Genetics FLGT Stock Holding History

Element Capital Management’s Portfolio FLGT Stock Details FLGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-21,103
Closed -$135K – 76
2017
Q2 		$135K Buy
+21,103
New +$170K 0.03% 124

Other funds holding FLGT

Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.81B AUM 83.9% 1-Year Est. Return
SC
Scholtz & Company Stamford, Connecticut $200M AUM 12.67% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $5.69B AUM 60.64% 1-Year Est. Return
USAA
United Services Automobile Association San Antonio, Texas $1.24B AUM 2.91% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $38.4B AUM 25.71% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Element Capital Management's FLGT Position: Q3 2017 in Review

Element Capital Management sold out of Fulgent Genetics (FLGT) in Q3 2017, closing a stake of 21,103 shares — an estimated $135K sold.

Element Capital Management first reported a position in FLGT in Q2 2017 and held it in 1 quarter. The position peaked at $135K in Q2 2017. 21 funds tracked by Wall St. Rank hold FLGT as of Q3 2017.

  • Element Capital Management reported no remaining Fulgent Genetics position as of Q3 2017 after selling out during the quarter.
  • Element Capital Management sold 21,103 Fulgent Genetics shares in Q3 2017, an estimated $135K.
  • Element Capital Management first reported a position in Fulgent Genetics in Q2 2017 and held it in 1 quarter.
  • Element Capital Management's Fulgent Genetics position peaked at $135K in Q2 2017.
  • 21 funds tracked by Wall St. Rank held Fulgent Genetics as of Q3 2017.

Based on Element Capital Management's 13F filing for Q3 2017, filed 13 Nov 2017.